SCHEMBL158017

SCHEMBL158017

CN1CC=C(c2cccc3sccc23)CC1

nearest known ligand 0.54

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 2/20 0.47
KDM4E B2RXH2 1/20 0.47
LMNA P02545 1/20 0.47
POLB P06746 1/20 0.47
HTR1A P08908 1/20 0.47
ALOX15 P16050 1/20 0.47
HTR6 P50406 1/20 0.47
HSD17B10 Q99714 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
DRD2 P14416 4/20 0.44
DRD4 P21917 4/20 0.44
QDPR P09417 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11874262 0.81 HTR6 (0.55) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL7255363 0.76 HTR6 (0.58) SLC6A4KDM4ELMNAPOLBHTR1A
Bromide SCHEMBL9325716 0.75 HTR6 (0.57) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL5008976 0.71 SLC6A4 (0.68) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL6594982 0.71 HTR2C (0.47) KDM4EALOX15HSD17B10DRD2QDPR
Bromide SCHEMBL7870845 0.70 HTR6 (0.42) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL1078756 0.70 KDM4E (0.55) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL29387382 0.70 KDM4E (0.55) SLC6A4KDM4ELMNAPOLBHTR1A
Hydrochloric Acid SCHEMBL2263936 0.70 KDM4E (0.55) SLC6A4KDM4ELMNAPOLBHTR1A
SCHEMBL5153625 0.70 ADRA2A (0.56) SLC6A4KDM4ELMNAHTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
US-8362252-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2013-01-29 US disclosed
EP-1797082-B1 CARBOSTYRIL COMPOUND OTSUKA PHARMA CO LTD (JP) 2012-08-29 EP disclosed
EP-2426128-A1 Carbostyril compound Otsuka Pharmaceutical Co., Limited (JP) 2012-03-07 EP disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-20100261705-A1 CARBOSTYRIL COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2010-10-14 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-7777038-B2 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-08-17 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed
US-20070179173-A1 Carbostyril compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179173-A1 Carbostyril compound GTF2F1, F3, GTF2F2 SLC6A4 3312/4885KDM4E 3919/4885LMNA 4860/4885
US-20100261705-A1 CARBOSTYRIL COMPOUND GTF2F1, F3, GTF2F2 SLC6A4 3312/4885KDM4E 3919/4885LMNA 4860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.